BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 32846846)

  • 1. Decreased expression of TNFRSF12A in thyroid gland cancer predicts poor prognosis: A study based on TCGA data.
    Wu ZH; Niu X; Wu GH; Cheng Q
    Medicine (Baltimore); 2020 Aug; 99(34):e21882. PubMed ID: 32846846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High ubiquitin conjugating enzyme E2 T mRNA expression and its prognostic significance in lung adenocarcinoma: A study based on the TCGA database.
    Wu ZH; Zhang YJ; Sun HY
    Medicine (Baltimore); 2020 Jan; 99(4):e18543. PubMed ID: 31977847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High GJB2 mRNA expression and its prognostic significance in lung adenocarcinoma: a study based on the TCGA database.
    Tang Y; Zhang YJ; Wu ZH
    Medicine (Baltimore); 2020 Apr; 99(14):e19054. PubMed ID: 32243356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance and diagnostic value of QPCT, SCEL and TNFRSF12A in papillary thyroid cancer.
    Liang T; Wu X; Wang L; Ni Z; Fan Y; Wu P; Wang H; Niu Y; Huang H
    Pathol Res Pract; 2023 May; 245():154431. PubMed ID: 37060824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High TNFRSF12A level associated with MMP-9 overexpression is linked to poor prognosis in breast cancer: Gene set enrichment analysis and validation in large-scale cohorts.
    Yang J; Min KW; Kim DH; Son BK; Moon KM; Wi YC; Bang SS; Oh YH; Do SI; Chae SW; Oh S; Kim YH; Kwon MJ
    PLoS One; 2018; 13(8):e0202113. PubMed ID: 30142200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-149-5p inhibits cell growth by regulating TWEAK/Fn14/PI3K/AKT pathway and predicts favorable survival in human osteosarcoma.
    Xu RD; Feng F; Yu XS; Liu ZD; Lao LF
    Int J Immunopathol Pharmacol; 2018; 32():2058738418786656. PubMed ID: 30014744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of LncRNA HOTAIR is Associated with Poor Prognosis in Thyroid Carcinoma: A Study Based on TCGA and GEO Data.
    Li HM; Yang H; Wen DY; Luo YH; Liang CY; Pan DH; Ma W; Chen G; He Y; Chen JQ
    Horm Metab Res; 2017 May; 49(5):388-399. PubMed ID: 28351094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ThPOK transcriptionally inactivates TNFRSF12A to increase the proliferation of T cells with the involvement of the NF-kB pathway.
    Xia L; Jiang L; Chen Y; Zhang G; Chen L
    Cytokine; 2021 Dec; 148():155658. PubMed ID: 34353698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide scanning for CHD1L gene in papillary thyroid carcinoma complicated with type 2 diabetes mellitus.
    Kang YY; Li JJ; Sun JX; Wei JX; Ding C; Shi CL; Wu G; Li K; Ma YF; Sun Y; Qiao H
    Clin Transl Oncol; 2021 Dec; 23(12):2536-2547. PubMed ID: 34245428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression of Cyclin F in liver cancer predicts poor prognosis: A study based on TCGA database.
    Zelong Y; Han Y; Ting G; Yifei W; Kun H; Haoran H; Yong C
    Medicine (Baltimore); 2021 Aug; 100(31):e26623. PubMed ID: 34397798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of key genes and miRNAs markers of papillary thyroid cancer.
    Qiu J; Zhang W; Zang C; Liu X; Liu F; Ge R; Sun Y; Xia Q
    Biol Res; 2018 Nov; 51(1):45. PubMed ID: 30414611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased expression of TFAP2B in endometrial cancer predicts poor prognosis: A study based on TCGA data.
    Wu H; Zhang J
    Gynecol Oncol; 2018 Jun; 149(3):592-597. PubMed ID: 29602546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HOXC10 up-regulation contributes to human thyroid cancer and indicates poor survival outcome.
    Feng X; Li T; Liu Z; Shi Y; Peng Y
    Mol Biosyst; 2015 Nov; 11(11):2946-54. PubMed ID: 26279264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of the miRNA-27a and PPAR/RXRα signaling axis in patients with thyroid carcinoma.
    Toraih EA; Fawzy MS; Abushouk AI; Shaheen S; Hobani YH; Alruwetei AM; A Mansouri O; Kandil E; Badran DI
    Epigenomics; 2020 Oct; 12(20):1825-1843. PubMed ID: 32969715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of prognostic signatures for intermediate-risk papillary thyroid cancer.
    Brennan K; Holsinger C; Dosiou C; Sunwoo JB; Akatsu H; Haile R; Gevaert O
    BMC Cancer; 2016 Sep; 16(1):736. PubMed ID: 27633254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic and prognostic value of tumor-infiltrating B cells in lymph node metastases of papillary thyroid carcinoma.
    Yang Z; Yin L; Zeng Y; Li Y; Chen H; Yin S; Zhang F; Yang W
    Virchows Arch; 2021 Nov; 479(5):947-959. PubMed ID: 34148127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-Cell Transcriptome Analysis Reveals Inter-Tumor Heterogeneity in Bilateral Papillary Thyroid Carcinoma.
    Wang T; Shi J; Li L; Zhou X; Zhang H; Zhang X; Wang Y; Liu L; Sheng L
    Front Immunol; 2022; 13():840811. PubMed ID: 35515000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monte Carlo cross-validation analysis screens pathway cross-talk associated with Parkinson's disease.
    Li T; Tang W; Zhang L
    Neurol Sci; 2016 Aug; 37(8):1327-33. PubMed ID: 27146810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Has-MiR-196a-2 is up-regulated and acts as an independent unfavorable prognostic factor in thyroid carcinoma.
    Fu YT; Zhang DQ; Zhou L; Li SJ; Sun H; Liu XL; Zheng HB
    Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2707-2714. PubMed ID: 29771422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor genotype determines phenotype and disease-related outcomes in thyroid cancer: a study of 1510 patients.
    Yip L; Nikiforova MN; Yoo JY; McCoy KL; Stang MT; Armstrong MJ; Nicholson KJ; Ohori NP; Coyne C; Hodak SP; Ferris RL; LeBeau SO; Nikiforov YE; Carty SE
    Ann Surg; 2015 Sep; 262(3):519-25; discussion 524-5. PubMed ID: 26258321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.